{
    "id": "correct_subsidiary_00047_1",
    "rank": 73,
    "data": {
        "url": "https://evolvemeded.com/course/1821-supp",
        "read_more_link": "",
        "language": "en",
        "title": "Evolve Medical Education",
        "top_image": "https://evolvemeded.com/img-new/favicon/favicon-32x32.png",
        "meta_img": "https://evolvemeded.com/img-new/favicon/favicon-32x32.png",
        "images": [
            "https://evolvemeded.com/img-new/x@2x.png",
            "https://evolvemeded.com/img-new/logo1.png",
            "https://evolvemeded.com/img-new/logo1.png",
            "https://evolvemeded.com/img-new/logo-footer.png",
            "https://evolvemeded.com/img-new/onetrust_light@2x.png"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "",
        "meta_lang": "",
        "meta_favicon": "https://evolvemeded.com/img-new/favicon/apple-touch-icon.png",
        "meta_site_name": "",
        "canonical_link": null,
        "text": "Supported from an educational grant from Ortho Dermatologics, Inc.\n\nLearning Objectives\n\nUpon completion of this activity, the participant should be able to:\n\nDescribe the psychological comorbidities associated with psoriasis.\n\nReview the proposed role of systemic inflammation in the pathophysiology of the psychological comorbidities associated with psoriasis, and the implications these findings have for the treatment of psoriasis.\n\nReview and identify strategies to assess patients with psoriasis for psychological comorbidities.\n\nAccreditation and Designation Statement\n\nAccreditation Statement\n\nEvolve Medical Education LLC (Evolve) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.\n\nCredit Designation Statement\n\nEvolve designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.\n\nFaculty and Disclosures\n\nThe following faculty/staff members have the following financial relationships with commercial interests:\n\nJerry Bagel, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Grant/Research Support: AbbVie; Boehringer-Ingelheim, Celgene, Eli-Lilly, Janssen, and Novartis. Speaker’s Bureau: AbbVie; Celgene, Eli-Lilly, Janssen, and Novartis.\n\nRichard G. Fried, MD, PhD, has no financial relationships with commercial interests.\n\nLeon Kircik, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Advisory Board: Aclaris, Allergan, Inc., Almirall, Anacor Pharmaceuticals, Biogen-Idec, Colbar, Celgene, Cipher, Connetics Corporation, EOS, Exeltis, Ferndale Laboratories, Inc., Galderma Laboratories, LP, Genentech, Inc., Intendis, Innocutis, Isdin, Johnson & Johnson, Nano Bio, OrthoNeutrogena, Promius, Quinnova, SkinMedica, Inc., Stiefel Laboratories, Inc., Sun Pharma, Valeant Pharmaceuticals Intl/Ortho Dermatologics, and Warner-Chilcott. Consultant: Allergan, Inc., Almirall, Amgen, Inc., Anacor Pharmaceuticals, Colbar, Cipher, CollaGenex, Connetics Corporation, Exeltis, Galderma Laboratories, LP, Genentech, Inc., Intendis, Isdin, Johnson & Johnson, Laboratory Skin Care Inc., Leo, Medical International Technologies, Merck, Merz, Novartis AG, OrthoNeutrogena, Promius, PuraCap, SkinMedica, Inc., Stiefel Laboratories, Inc., Sun Pharma, Taro, UCB, Valeant Pharmaceuticals Intl/Ortho Dermatologics, and ZAGE. Grant/Research Support: Acambis, Allergan, Inc., Amgen, Inc., Anacor Pharmaceuticals, Astellas Pharma US, Inc., Asubio, Berlex Laboratories, Biolife, Biopelle, Boehringer-Ingelheim, Breckinridge Pharma, Celgene, Centocor, Inc., Cellceutix, Coherus, CollaGenex, Combinatrix, Connetics Corporation, Coria, Dermavant, Dermira, Dow Pharmaceutical Sciences, Inc., Dusa, Eli Lilly, Exeltis, Ferndale Laboratories, Inc., Galderma Laboratories, LP, Genentech, Inc., GlaxoSmithKline, PLC, Health Point, LTD, Idera, Intendis, Johnson & Johnson, Leo, L’Oréal, 3M, Maruho, Merck, Medicis Pharmaceutical Corp., Nano Bio, Novartis AG, Noven Pharmaceuticals, Nucryst Pharmaceuticals Corp, Obagi, Onset, OrthoNeutrogena, Promius, QLT, Inc., PharmaDerm, Pfizer, Quinnova, Quatrix, SkinMedica, Inc., Stiefel Laboratories, Inc., Sun Pharma, TolerRx, UCB, Valeant Pharmaceuticals Intl/Ortho Dermatologics, Warner-Chilcott, and XenoPort. Speaker’s Bureau: Abbott Laboratories, Allergan, Inc., Amgen, Inc., Assos Pharma, Astellas Pharma US, Inc., Cipher, CollaGenex, Connetics Corporation, Dermik Laboratories, Embil Pharmaceuticals, Exeltis, Galderma Laboratories, LP, Genentech, Inc., Innocutis, Innovail, Johnson & Johnson, Leo, L’Oréal, 3M, Onset, OrthoNeutrogena, PediaPharma, PharmaDerm, Serono, SkinMedica, Inc., Stiefel Laboratories, Inc., Sun Pharma, Taro, Triax, UCB, Valeant Pharmaceuticals Intl/Ortho Dermatologics, and Warner-Chilcott. Stock/Shareholder: Johnson & Johnson.\n\nJashin J. Wu, M.D., has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: AbbVie, Almirall, Amgen, Bristol-Myers Squibb, Celgene, Dermira, Dr. Reddy's Laboratories, Eli Lilly, Janssen, LEO Pharma, Novartis, Ortho Dermatologics, Promius Pharma, Regeneron, Sun Pharmaceutical, and UCB. Grant/Research Support: AbbVie, Amgen, Eli Lilly, Janssen, and Novartis. Speaker’s Bureau: Celgene, Novartis, Sun Pharmaceutical, UCB, and Valeant Pharmaceuticals Intl/Ortho Dermatologics.\n\nEditorial Support Disclosures\n\nErin K. Fletcher, MIT, director of compliance and education, Susan Gallagher-Pecha, director of client services and project management Evolve; and Kristen Richardson, writer have no financial relationships with commercial interests., Neil Shah, MD, peer reviewer, has no financial relationships with commercial interests.\n\nDisclaimer\n\nOff-Label Statement\n\nThis educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings."
    }
}